Avita Medical | 1811094D - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Accuray USD 116.17M 14.63M 2024-12
Celltrion KRW 92.83B 14.59B 2026-03
Clinuvel Pharmaceuticals AUD 2.64M 1.06M 2025-12
Cochlear AUD 319.2M 160.35M 2025-12
CSL USD 3.87B 2.08B 2025-12
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 11.19B 1.2B 2026-06
Kangmei Pharma CNY 841.45M 271.27M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Mayne Pharma AUD 43.74M 2.67M 2024-06
Medical Developments International AUD 7.09M 4.91M 2025-12
Nanosonics AUD 24.22M 1.11M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Organigram Holdings CAD 43.39M 13.54M 2026-03
Pacific Edge NZD 280K 0 2024-03
Paradigm Biopharmaceuticals AUD 4.5K 2.62K 2025-12
Pharma Mar EUR 4.73M 1.08M 2026-06
Polynovo AUD 9.02M 3.51M 2025-12
Qiagen NV USD 196.45M 13.73M 2026-06
Ramsay Health Care AUD 3.05B 78.7M 2025-12
ResMed USD 540.43M 4.15M 2026-03
Sartorius EUR 478.7M 5.9M 2026-06
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Telix Pharmaceuticals AUD 245.71M 24.35M 2026-06
Tilray USD 164.37M 8.41M 2025-09
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.17B 418.33M 2026-06